Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Access Pharmaceuticals Inc. (ACCP.OB)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ACCP.OB
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Access Pharma Looking for Smooth U.S. MuGard Launch in 2010
Mike Havrilla
•
Nov 11
•
1 Comment
Updates on Access Pharma, BioSphere Medical, CryoLife, NeoPharm
Mike Havrilla
•
Oct 28
•
2 Comments
Access Pharma: Clinical and Commercial MuGard Updates
Mike Havrilla
•
Oct 15
•
1 Comment
Access Pharma and iMedicor Sign e-Marketing Deal for MuGard
Mike Havrilla
•
Oct 06
•
Comment!
Access Pharma's Prospects Look Good Even Without a Buyout
VFC's Stock House
•
Oct 05
•
4 Comments
Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities
Mike Havrilla
•
Sep 30
•
4 Comments
More articles on ACCP.OB »
Instablogs
Access Pharmaceuticals
Sat October 3, 2009
•
Jack Haddad
•
1 Comment
Access Pharma (OTC:ACCP): Deep Pipeline, Shallow Valuation
Tue July 14, 2009
•
Mike Havrilla
•
Comment!
Why MuGard Will Be Successful
Sun July 5, 2009
•
Michael Catalin Vlaicu
•
1 Comment
Write a post on ACCP.OB
|
More Instablogs on ACCP.OB »
Sentiment
What advice would you give to
ACCP.OB?
120 characters left
What's your view of ACCP.OB?
Make sure you include ACCP.OB
140 characters left
|
Settings
MicrocapMan
: Access Pharma (
ACCP.OB
) breaking out 2nd day in a row after positive new study on its FDA approved product, MuGard.
Fri, Jul 24, 2009
More StockTalks on ACCP.OB »